A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
Clinical trial NCT01245816 · WITHDRAWN
Trial details
- NCT number
- NCT01245816
- Sponsor
- Cancer Prevention Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.